サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：肺炎検査の世界市場規模調査・予測：製品タイプ別、タイプ別、エンドユーザー別、地域別分析、2022-2029年
市場調査レポート
商品コード
1215433

肺炎検査の世界市場規模調査・予測：製品タイプ別、タイプ別、エンドユーザー別、地域別分析、2022-2029年

Global Pneumonia Testing Market Size study & Forecast, by Product Type by Type, by End-user and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
肺炎検査の世界市場規模調査・予測：製品タイプ別、タイプ別、エンドユーザー別、地域別分析、2022-2029年
出版日: 2023年02月08日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

肺炎と呼ばれる肺の感染症は、細菌、真菌、またはウイルスによって引き起こされます。

肺の中にある気嚢である肺胞が炎症を起こし、液体や膿で腫れあがります。咳、発熱、悪寒、呼吸困難などは、頻繁に見られる肺炎の症状の一部です。肺炎の検査は、身体検査、病歴聴取、胸部X線検査、血液培養、パルスオキシメトリ、喀痰培養、気管支鏡検査、体液採取などで行われます。肺炎に対する関心の高まりは、この疾患の有病率の増加と早期診断につながっています。また、POC（ポイント・オブ・ケア）検査の普及や核酸検出などの技術進歩、高齢者人口の増加も成長の要因となっています。

肺炎の有病率の上昇は、予測期間中に肺炎検査市場の有利な需要を創出するでしょう。例えば、2019年のユニセフ（国連国際児童基金）の記事によると、世界では人口10万人あたり1,400件以上の肺炎の症例があるそうです。さらに、子ども10万人あたり、それぞれ2,500件、1,620件で、南アジアと西・中央アフリカが最も多く発生しています。したがって、上記の理由は市場の重要な成長促進要因となっています。さらに、肺炎検査における技術の進歩は、この成長を促進することが期待される重要な側面の1つです。より高い検出効率は、肺炎を診断するための高度なマルチプレックスPCR（mPCR）ベースの技術によって提供され、コストと時間を最小限に抑えることができます。例えば、2018年、米国では、Curetis社がUnyvero SystemとLRT Cartridgeを発売しました。この方法は、強力なマルチプレックスPCR技術を活用し、サンプルから反応までの幅広い範囲の細菌、抗生物質耐性の指標、または毒素を簡単に判定することができます。また、ポイントオブケア（POC）検査の利用が増加していることも、予測期間中に市場にとって有利な機会を生み出すと考えられます。しかし、肺炎の検出に不可欠なツールとして胸部X線が広く利用されていることが、2022年から2029年の予測期間を通じて市場の成長を阻害しています。

世界の肺炎検査市場の調査において考慮された主要地域は、アジア太平洋、北米、欧州、中南米、世界のその他の地域です。北米は、肺炎患者数の増加、有利な償還政策、ポイントオブケア技術の採用拡大により、市場シェアの点で世界を支配する地域となっています。一方、アジア太平洋地域は、高齢者人口の増加や肺炎患者の増加などの要因により、予測期間中に高い成長率を示すと予想され、アジア太平洋地域の肺炎検査市場にとって有利な成長見通しを生み出すと考えられます。

本調査の目的は、近年における様々なセグメントと国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的側面と量的側面の両方を取り込むように設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメンテーション市場の推定・予測、2019年～2029年
    • 肺炎検査市場：地域別、2019年～2029年
    • 肺炎検査市場：製品タイプ別、2019年～2029年
    • 肺炎検査市場、タイプ別、2019-2029年
    • 肺炎検査市場：エンドユーザー別、2019-2029年
  • 主な動向
  • 調査手法の紹介
  • 調査前提条件

第2章 肺炎検査の世界市場の定義と範囲

  • 調査の目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 肺炎検査の世界市場力学

  • 肺炎検査市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 肺炎の有病率の上昇
      • 肺炎検査における技術の進歩
    • 市場の課題
      • 肺炎検出の必須ツールとしての胸部レントゲンの活用
    • 市場機会
      • ポイント・オブ・ケア（POC）検査の利用拡大

第4章 肺炎検査の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • トップ投資機会
  • 主要成功戦略
  • 業界専門家別展望
  • アナリストの結論・提言

第5章 リスクアセスメント：COVID-19のインパクト

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 肺炎検査の世界市場：製品タイプ別

  • 市場スナップショット
  • 肺炎検査の世界市場：製品タイプ別、パフォーマンス-ポテンシャル分析
  • 肺炎検査の世界市場、製品タイプ別推定・予測2019～2029年
  • 肺炎検査の世界市場、サブセグメント分析
    • インスツルメンツ
    • 試薬・消耗品

第7章：肺炎検査の世界市場、タイプ別

  • 市場スナップショット
  • 肺炎検査の世界市場：タイプ別）、パフォーマンス-ポテンシャル分析
  • 肺炎検査の世界市場、タイプ別推定・予測2019～2029年
  • 肺炎検査市場、サブセグメント分析
    • 溶連菌ベース
    • レジオネラ菌ベース
    • クラミドフィラ系
    • ウイルス性肺炎ベース
    • 肺炎マイコプラズマ系
    • その他

第8章 肺炎検査の世界市場：エンドユーザー別

  • 市場スナップショット
  • 肺炎検査の世界市場：エンドユーザー別実績-ポテンシャル分析
  • 肺炎検査の世界市場、エンドユーザー別推定・予測2019-2029
  • 肺炎検査の市場、サブセグメント分析
    • 病院・診療所
    • 診断センター
    • その他

第9章：肺炎検査の世界市場：地域別分析

  • 肺炎検査市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品タイプ別の推定・予測、2019年～2029年
      • タイプ別の推定・予測、2019年～2029年
      • エンドユーザー別の推定・予測、2019年～2029年
    • カナダ
  • 欧州肺炎検査市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州地域
  • アジア太平洋地域の肺炎検査市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの肺炎検査市場のスナップショット
    • ブラジル
    • メキシコ
    • その他のラテンアメリカ地域
  • 世界のその他の地域

第10章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Quidel Corporation（U.S.）
      • 主要情報
      • 概要
      • 財務情報（データの入手状況により異なります）
      • 製品概要
      • 最近の動向
    • Abbott（U.S.）
    • bioMerieux SA（France）
    • Thermo Fisher Scientific Inc.（U.S.）
    • INTEC（China）
    • OpGen（U.S.）
    • Meridian Bioscience, Inc.（U.S.）
    • BD（Becton, Dickinson, and Company）（U.S.）
    • Luminex Corporation（DiaSorin S.p.A.）（U.S.）
    • Roche Holding AG（Switzerland）

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査属性
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Pneumonia Testing Market, report scope
  • TABLE 2. Global Pneumonia Testing Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Pneumonia Testing Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
  • TABLE 4. Global Pneumonia Testing Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 5. Global Pneumonia Testing Market estimates & forecasts by End-user 2019-2029 (USD Billion)
  • TABLE 6. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Pneumonia Testing Market
  • TABLE 71. List of primary sources, used in the study of global Pneumonia Testing Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Pneumonia Testing Market, research methodology
  • FIG 2. Global Pneumonia Testing Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Pneumonia Testing Market, key trends 2021
  • FIG 5. Global Pneumonia Testing Market, growth prospects 2022-2029
  • FIG 6. Global Pneumonia Testing Market, porters 5 force model
  • FIG 7. Global Pneumonia Testing Market, pest analysis
  • FIG 8. Global Pneumonia Testing Market, value chain analysis
  • FIG 9. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Pneumonia Testing Market, regional snapshot 2019 & 2029
  • FIG 15. North America Pneumonia Testing Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Pneumonia Testing Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Pneumonia Testing Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Pneumonia Testing Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Pneumonia Testing Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Pneumonia Testing Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. A lung infection known as pneumonia is caused by the bacteria, fungus, or viruses. Alveoli, the air sacs in the lungs, become inflamed and swell with fluid or pus as a result of the infection. Cough, fever, chills, and breathing difficulties are a few of the pneumonia symptoms that are frequently seen. Physical examination, evaluation of medical history, chest X-ray, blood culture, pulse oximetry, sputum culture, bronchoscopy, and fluid sample make the pneumonia testing process for this disease. The rise in concerns about pneumonia has led to an increase in the prevalence of the disease and early diagnosis. Also, another factor driving the growth is Increased use of point of care (POC) testing and technological advancements, such as nucleic acid detection worldwide, as well as a growth in the number of geriatric populations.

The rising prevalence of pneumonia will create the lucrative demand for the pneumonia testing market during forecast period. For instance, according to a 2019 UNICEF (United Nations International Children's Emergency Fund) article, there are more than 1,400 cases of pneumonia per 100,000 people worldwide. Additionally, with 2,500 cases and 1,620 cases per 100,000 children, respectively, South Asia and West and Central Africa have the highest incidence of it. Therefore, the above reasons are significant growth drivers for the market. Additionally, technology advancements in pneumonia testing are one of the key aspects that are expected to fuel this growth. Higher detection efficiency is provided by the advanced multiplex PCR (mPCR) based technology for diagnosing pneumonia, which minimizes cost and time. For instance, in 2018, in the US, Curetis launched the Unyvero System and LRT Cartridge. The method utilizes powerful multiplex PCR technology to easily determine a wide range of bacteria, indicators of antibiotic resistance, or toxins from sample to response. Also, rising use of point of care (POC) testing would create the lucrative opportunity for the market during forecast period. However, the widespread utilization of chest X-rays as an essential tool for pneumonia detection stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pneumonia Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the rising number of pneumonia cases, favorable reimbursement policy and growing adoption of point-of-care technologies. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as increasing geriatric population and growing cases of pneumonia would create lucrative growth prospects for the Pneumonia Testing market across Asia Pacific region.

Major market players included in this report are:

Quidel Corporation (U.S.)

Abbott (U.S.)

bioMerieux SA (France)

Thermo Fisher Scientific Inc. (U.S.)

INTEC (China)

OpGen (U.S.)

Meridian Bioscience, Inc. (U.S.)

BD (Becton, Dickinson, and Company) (U.S.)

Luminex Corporation (DiaSorin S.p.A.) (U.S.)

Roche Holding AG (Switzerland)

Recent Developments in the Market:

  • September 2021: CerTest Biotec developed and tested its CE-IVD multiplex assay VIASURE M. pneumoniae, L. pneumophila and C. pneumoniae real-time PCR kit for detection of principal pathogens implicated in atypical pneumoniae.
  • February 2021: Mesa Biotech, Inc. was fully acquired by Thermo Fisher Scientific Inc. The company would be able to grow its molecular diagnostics sector with the acquisition.

Global Pneumonia Testing Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product Type, Type, End-user, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Instruments

Reagents & Consumables

By Type:

Streptococcus-based

Legionella-based

Chlamydophila-based

Viral Pneumonia-based

Mycoplasma Pneumonia-based

Others

By End-user:

Hospitals & Clinics

Diagnostic Centers

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Pneumonia Testing Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Pneumonia Testing Market, by Product Type, 2019-2029 (USD Billion)
    • 1.2.3. Pneumonia Testing Market, by Type, 2019-2029 (USD Billion)
    • 1.2.4. Pneumonia Testing Market, by End-user, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pneumonia Testing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pneumonia Testing Market Dynamics

  • 3.1. Pneumonia Testing Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising Prevalence of Pneumonia
      • 3.1.1.2. Technology advancements in pneumonia testing
    • 3.1.2. Market Challenges
      • 3.1.2.1. Utilization of chest x-rays as an essential tool for pneumonia detection
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising use of point of care (poc) testing

Chapter 4. Global Pneumonia Testing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pneumonia Testing Market, by Product Type

  • 6.1. Market Snapshot
  • 6.2. Global Pneumonia Testing Market by Product Type, Performance - Potential Analysis
  • 6.3. Global Pneumonia Testing Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
  • 6.4. Pneumonia Testing Market, Sub Segment Analysis
    • 6.4.1. Instruments
    • 6.4.2. Reagents & Consumables

Chapter 7. Global Pneumonia Testing Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Pneumonia Testing Market by Type, Performance - Potential Analysis
  • 7.3. Global Pneumonia Testing Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 7.4. Pneumonia Testing Market, Sub Segment Analysis
    • 7.4.1. Streptococcus-based
    • 7.4.2. Legionella-based
    • 7.4.3. Chlamydophila-based
    • 7.4.4. Viral Pneumonia-based
    • 7.4.5. Mycoplasma Pneumonia-based
    • 7.4.6. Others

Chapter 8. Global Pneumonia Testing Market, by End-user

  • 8.1. Market Snapshot
  • 8.2. Global Pneumonia Testing Market by End-user, Performance - Potential Analysis
  • 8.3. Global Pneumonia Testing Market Estimates & Forecasts by End-user 2019-2029 (USD Billion)
  • 8.4. Pneumonia Testing Market, Sub Segment Analysis
    • 8.4.1. Hospitals & Clinics
    • 8.4.2. Diagnostic Centers
    • 8.4.3. Others

Chapter 9. Global Pneumonia Testing Market, Regional Analysis

  • 9.1. Pneumonia Testing Market, Regional Market Snapshot
  • 9.2. North America Pneumonia Testing Market
    • 9.2.1. U.S. Pneumonia Testing Market
      • 9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Pneumonia Testing Market
  • 9.3. Europe Pneumonia Testing Market Snapshot
    • 9.3.1. U.K. Pneumonia Testing Market
    • 9.3.2. Germany Pneumonia Testing Market
    • 9.3.3. France Pneumonia Testing Market
    • 9.3.4. Spain Pneumonia Testing Market
    • 9.3.5. Italy Pneumonia Testing Market
    • 9.3.6. Rest of Europe Pneumonia Testing Market
  • 9.4. Asia-Pacific Pneumonia Testing Market Snapshot
    • 9.4.1. China Pneumonia Testing Market
    • 9.4.2. India Pneumonia Testing Market
    • 9.4.3. Japan Pneumonia Testing Market
    • 9.4.4. Australia Pneumonia Testing Market
    • 9.4.5. South Korea Pneumonia Testing Market
    • 9.4.6. Rest of Asia Pacific Pneumonia Testing Market
  • 9.5. Latin America Pneumonia Testing Market Snapshot
    • 9.5.1. Brazil Pneumonia Testing Market
    • 9.5.2. Mexico Pneumonia Testing Market
    • 9.5.3. Rest of Latin America Pneumonia Testing Market
  • 9.6. Rest of The World Pneumonia Testing Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Quidel Corporation (U.S.)
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Abbott (U.S.)
    • 10.2.3. bioMerieux SA (France)
    • 10.2.4. Thermo Fisher Scientific Inc. (U.S.)
    • 10.2.5. INTEC (China)
    • 10.2.6. OpGen (U.S.)
    • 10.2.7. Meridian Bioscience, Inc. (U.S.)
    • 10.2.8. BD (Becton, Dickinson, and Company) (U.S.)
    • 10.2.9. Luminex Corporation (DiaSorin S.p.A.) (U.S.)
    • 10.2.10. Roche Holding AG (Switzerland)

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption